Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	February 2026 P I P E Transaction	February 2026 P I P E Transaction February 2026 common warrants	May 2025 PIPE Transaction	May 2025 PIPE Transaction Series B Warrants	April 2025 PIPE Transaction	Common Stock	Common Stock February 2026 P I P E Transaction February 2026 common warrants	Common Stock February 2026 P I P E Transaction February 2026 Prefunded Warrants	Common Stock May 2025 PIPE Transaction	Common Stock May 2025 PIPE Transaction Series B Warrants	Common Stock April 2025 PIPE Transaction	Common Stock January 2024 PIPE Transaction	Additional Paid-In Capital	Additional Paid-In Capital February 2026 P I P E Transaction	Additional Paid-In Capital February 2026 P I P E Transaction February 2026 common warrants	Additional Paid-In Capital May 2025 PIPE Transaction	Additional Paid-In Capital May 2025 PIPE Transaction Series B Warrants	Additional Paid-In Capital April 2025 PIPE Transaction	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024							9,015,087
Beginning balance at Dec. 31, 2024	$ 18,429						$ 1							$ 525,618						$ 4,209	$ (511,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,473)																				(25,473)
Stock-based compensation	2,042													2,042
Foreign exchange translation adjustment	(285)																			(285)
Ending balance (in shares) at Mar. 31, 2025							9,015,087
Ending balance at Mar. 31, 2025	(5,287)						$ 1							527,660						3,924	(536,872)
Beginning balance (in shares) at Dec. 31, 2024							9,015,087
Beginning balance at Dec. 31, 2024	18,429						$ 1							525,618						4,209	(511,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(77,872)
Reclassification of SARs liability to equity	0
Foreign exchange translation adjustment	(1,627)
Ending balance (in shares) at Sep. 30, 2025							9,865,060
Ending balance at Sep. 30, 2025	10,499						$ 1							597,187						2,582	(589,271)
Beginning balance (in shares) at Mar. 31, 2025							9,015,087
Beginning balance at Mar. 31, 2025	(5,287)						$ 1							527,660						3,924	(536,872)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(26,820)																				(26,820)
Stock-based compensation	1,899													1,899
Foreign exchange translation adjustment	(1,399)																			(1,399)
Issuance of pre-funded warrants				$ 60,661													$ 60,661
Issuance of common stock (in shares)												566,667
Issuance of common stock						$ 4,734						$ 0							$ 4,734
Exercise of warrants (in shares)													261,306
Shares issued in connection with the Company's employee stock purchase plan (in shares)							22,000
Shares issued in connection with the Company's employee stock purchase plan	123													123
Ending balance (in shares) at Jun. 30, 2025							9,865,060
Ending balance at Jun. 30, 2025	33,911						$ 1							595,077						2,525	(563,692)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,579)																				(25,579)
Stock-based compensation	2,110													2,110
Foreign exchange translation adjustment	57																			57
Ending balance (in shares) at Sep. 30, 2025							9,865,060
Ending balance at Sep. 30, 2025	$ 10,499						$ 1							597,187						2,582	(589,271)
Beginning balance (in shares) at Dec. 31, 2025	15,880,822						12,038,263
Beginning balance at Dec. 31, 2025	$ (6,673)						$ 1							599,249						2,648	(608,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(32,588)																				(32,588)
Stock-based compensation	1,443													1,443
Foreign exchange translation adjustment	409																			409
Issuance of common stock		$ 187,263													$ 187,263
Exercise of warrants (in shares)										1,383,220	200,000
Exercise of warrants				$ 0	$ 1,377													$ 1,377
Ending balance (in shares) at Mar. 31, 2026							13,621,483
Ending balance at Mar. 31, 2026	$ 151,231						$ 1							789,332						3,057	(641,159)
Beginning balance (in shares) at Dec. 31, 2025	15,880,822						12,038,263
Beginning balance at Dec. 31, 2025	$ (6,673)						$ 1							599,249						2,648	(608,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(108,996)
Reclassification of SARs liability to equity	5,198
Foreign exchange translation adjustment	$ 101
Ending balance (in shares) at Sep. 30, 2026	12,038,263						15,880,822
Ending balance at Sep. 30, 2026	$ 104,473						$ 1							819,290						2,749	(717,567)
Beginning balance (in shares) at Mar. 31, 2026							13,621,483
Beginning balance at Mar. 31, 2026	151,231						$ 1							789,332						3,057	(641,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(34,099)																				(34,099)
Stock-based compensation	5,416													5,416
Reclassification of SARs liability to equity	5,198													5,198
Foreign exchange translation adjustment	(285)																			(285)
Shares issued in connection with the Company's employee stock purchase plan (in shares)							18,884
Shares issued in connection with the Company's employee stock purchase plan	86													86
Exercise of employee stock options (in shares)							4,100
Exercise of employee stock options	32													32
Ending balance (in shares) at Jun. 30, 2026							13,644,467
Ending balance at Jun. 30, 2026	127,579						$ 1							800,064						2,772	(675,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(42,309)																				(42,309)
Stock-based compensation	13,908													13,908
Foreign exchange translation adjustment	(23)																			(23)
SARs exercised (in shares)							46,946
Exercise of February 2026 Common Warrants, net of issuance costs (in shares)								612,700
Exercise of February 2026 Common Warrants, net of issuance costs of $321,000			$ 5,029													$ 5,029
Exercise of warrants (in shares)									612,644	499,970	430,180
Exercise of employee stock options (in shares)							33,915
Exercise of employee stock options	$ 289													289
Ending balance (in shares) at Sep. 30, 2026	12,038,263						15,880,822
Ending balance at Sep. 30, 2026	$ 104,473						$ 1							$ 819,290						$ 2,749	$ (717,567)